Press Releases
February 22, 2024
Real Endpoints announces upgrades to RE Assist, creating the most comprehensive source of fund information to support patient access to prescription medications
Real Endpoints, the leading market-access platform and advisory firm, announces the March 31, 2024 release of its upgraded version of RE Assist, which uses a proprietary AI crawler plus human curation to identify and validate new sources of copay and deductible foundation support for patients and caregivers.
read full press release >
April 13, 2023
Real Endpoints announces four biopharma clients have signed on as customers for RE Assist, a tech-enabled AI platform providing real-time foundation fund information to Medicare patients
Real Endpoints, the leading market-access platform and advisory firm, announces that four biopharma companies with combined 2022 sales of nearly $8 billion have signed contracts to offer Real Endpoint's RE Assist tool to support Medicare patients in need of deductible and copay assistance. RE Assist provides actionable, comprehensive foundation fund information in a compliant and easy to navigate format.
read full press release >
February 3, 2023
The Value Based Care Council of NAMCP, a non-profit association of medical directors and physicians, and Real Endpoints LLC, a strategic market access consultancy leading in innovative contracting, announce the publication of a new manuscript, “Major Trends In Innovative Contracting: A Survey of Payers and Industry
This manuscript lays the groundwork for greater payer and industry collaboration around value-based agreements (VBAs) as a next-generation benefit management strategy.
read full press release >
October 4, 2022
Real Endpoints Marketplace announces collaboration with bluebird bio to help scale delivery of a first-of-its-kind value-based contract for one-time gene therapy
The risk-sharing agreement removes economic uncertainties, enabling regional and mid-sized health plans to provide patients with transfusion-dependent beta-thalassemia access to ZYNTEGLO
read full press release >
September 6, 2022
Real Endpoints’ Chief Clinical Officer, Dr. Jane Barlow, named to PharmaVOICE 100
Citing her creativity and ability to develop practical market access strategies, PharmaVOICE magazine has named Dr. Jane Barlow, Executive Vice President and Chief Clinical Officer of Real Endpoints, to the PharmaVoice 100, an annual list that recognizes the most inspiring people in the life sciences industry. Jane is a national thought leader and critical voice on the development and implementation of innovative contracting models, as well as other existential issues around pharmaceutical pricing and reimbursement.
read full press release >
July 6, 2022
Real Endpoints and NAMCP’s Value Based Care Council Announce a New Collaboration Laying the Groundwork for Value-Based Agreements Between Health Plans and Manufacturers
The two organizations plan to develop and launch a multi-stakeholder survey to understand the key barriers and enablers and identify potential solutions that will accelerate value-based agreements as a next-generation benefit management strategy. Despite their promise in reducing the financial and clinical uncertainty of medicines, especially high-priced specialty products, value-based agreements remain a minority in the marketplace today.
read full press release >